1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
PAVmed Inc.

PAVmed Inc.

PAVM
PAVmed Inc.US flagNASDAQ Capital Market
5.28
USD
+0.19
- -
33.70MMarket Cap

Total Valuation

PAVmed Inc. carries a market capitalization of 33.70M, placing it among publicly traded companies globally. Its enterprise value stands at 44.59M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap33.70M
Enterprise Value44.59M

Share Statistics

PAVmed Inc. currently has 7.27M shares outstanding.

Shares Outstanding7.27M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 125.91, and the price-to-book ratio stands at 1.38.

PE RatioN/A
PS Ratio125.91
PB Ratio1.38
P/TBV Ratio1.38
P/FCF Ratio-1.84
P/OCF Ratio-1.82

Enterprise Valuation

EV / Sales398.15
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

PAVmed Inc. maintains a current ratio of 1.19, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 88.40, indicating elevated leverage, while an interest coverage ratio of -1,434.89 demonstrates limited ability to service its debt obligations.

Current Ratio1.19
Quick Ratio0.93
Debt / Equity88.40
Debt / EBITDA-0.66
Interest Coverage-1,434.89

Financial Efficiency

Return on Equity (ROE)-93.42
Return on Assets (ROA)-28.75
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.52

Stock Price Statistics

PAVmed Inc.'s stock has declined approximately -58.97436% over the past 52 weeks. The 50-day moving average sits at 5.24, while the 200-day moving average is 7.76.

Beta (5Y)N/A
52-Week Price Change-58.97436%
50-Day Moving Average5.24
200-Day Moving Average7.76
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, PAVmed Inc. generated 112,000.00 in revenue and converted that into -12.09M in net income, yielding earnings per share of -6.92. EBITDA reached -25.83M, while operating income came in at -25.91M.

Revenue112,000.00
Gross Profit-247,000.00
Operating Income-25.91M
Pretax Income-16.43M
Net Income-12.09M
EBITDA-25.83M
EBIT-25.91M
Earnings Per Share (EPS)-6.92

Balance Sheet

PAVmed Inc. holds 3.78M in cash and equivalents against 17.07M in total debt, resulting in a net debt position of 11.32M. Total book value stands at 31.20M, with working capital of 770,000.00 providing operational flexibility.

Cash & Cash Equivalents3.78M
Total Debt17.07M
Net Debt11.32M
Equity (Book Value)31.20M
Book Value Per Share4.29
Working Capital770,000.00

Cash Flow

PAVmed Inc. produced -7.73M in operating cash flow over the past twelve months. After subtracting -52,000.00 in capital expenditures, free cash flow totaled -7.78M - equivalent to -3.28 per share.

Operating Cash Flow-7.73M
Capital Expenditures-52,000.00
Free Cash Flow-7.78M
FCF Per Share-3.28

Margins

PAVmed Inc. operates with a gross margin of -220.54, reflecting its pricing power and cost economics. The operating margin of -23,131.25 and net profit margin of -10,794.64 provide insight into operational efficiency.

Gross Margin-220.54
Operating Margin-23,131.25
Pretax Margin-14,669.64
Profit Margin-10,794.64
EBITDA Margin-23,060.71

Dividends & Yields

The company's payout ratio of 29.13 indicates the proportion of earnings distributed to shareholders.

Dividend Per ShareN/A
Dividend YieldN/A
Payout Ratio29.13
Shareholder Yield-17.50
FCF Yield-54.44

Stock Splits

PAVmed Inc.'s most recent stock split took place on January 2, 2026 with a 30:1 split ratio.

Last Split Date1/2/2026
Split Ratio30:1

Scores

PAVmed Inc. posts an Altman Z-Score of -10.07, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-10.07